Y Intercept Hong Kong Ltd lifted its position in Colgate-Palmolive (NYSE:CL – Free Report) by 52.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 39,641 shares of the company’s stock after buying an additional 13,698 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Colgate-Palmolive were worth $3,604,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Chicago Partners Investment Group LLC increased its position in shares of Colgate-Palmolive by 16.2% in the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock worth $591,000 after purchasing an additional 943 shares during the last quarter. Peak Financial Advisors LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter worth approximately $1,315,000. Gordian Advisors LLC bought a new position in shares of Colgate-Palmolive in the third quarter worth approximately $602,000. Carrera Capital Advisors increased its position in shares of Colgate-Palmolive by 23.1% in the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after purchasing an additional 7,353 shares during the last quarter. Finally, Fiduciary Alliance LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter worth approximately $4,066,000. 80.41% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on CL shares. Raymond James restated an “outperform” rating and issued a $105.00 price objective (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. JPMorgan Chase & Co. decreased their price objective on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. Piper Sandler reduced their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. Royal Bank of Canada reiterated a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Finally, Morgan Stanley reduced their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $101.16.
Colgate-Palmolive Stock Performance
Shares of CL stock opened at $89.56 on Monday. The stock has a fifty day moving average of $88.94 and a 200 day moving average of $95.82. Colgate-Palmolive has a 52 week low of $84.45 and a 52 week high of $109.30. The firm has a market capitalization of $72.68 billion, a price-to-earnings ratio of 25.44, a PEG ratio of 4.20 and a beta of 0.44. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the business earned $0.87 earnings per share. As a group, research analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current year.
Colgate-Palmolive Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.23%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 56.82%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Top Stocks Investing in 5G Technology
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- Insider Trades May Not Tell You What You Think
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.